Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Chronic Spontaneous Urticaria

Does CSU Go Away Permanently? Can I Stop Medication?

At a Glance

Chronic spontaneous urticaria often eventually goes into remission, meaning hives and swelling stop without medication, but no test can predict when. Do not reduce or stop treatment on your own; symptoms may return and need a doctor-guided restart plan.

Many people with chronic spontaneous urticaria (CSU) eventually achieve remission, meaning their symptoms stop completely without the need for medication. CSU is widely considered a self-limiting condition that often resolves over time [1]. However, because the exact timing and durability of remission are unpredictable, stopping medication must be done carefully in partnership with your doctor. Medications for CSU suppress the hives and swelling, but they do not cure the condition itself. If you stop taking them while your disease is still active, your symptoms will likely return.

Important Safety Note: Ordinary CSU hives alone are not usually a medical emergency. However, if you develop swelling of your tongue, lips, or throat, have trouble breathing or swallowing, experience a change in your voice, or feel dizzy or faint, seek emergency medical care immediately. Do not wait to restart your routine medication. If you have been prescribed an epinephrine auto-injector for any reason, use it according to your emergency plan and seek care.

The Timeline for Natural Remission

While CSU can be frustrating, the natural course of the disease favors remission for many patients. However, there is no single routine blood test that can reliably predict exactly when your individual condition will end. Clinical studies tracking patients over time have shown varying rates of remission:

  • 1 Year: In a large study of adults, roughly 21% of patients achieved remission within the first year after their diagnosis [2]. Other reviews have seen rates ranging from 21% to 47% in the first year depending on the group studied [3].
  • 5 Years: By the five-year mark, cumulative remission estimates range from about 45% to 59%, meaning these patients were able to remain symptom-free without the need for medication for at least six months [2][4].

While it is often said that the typical disease duration is 2 to 5 years, this is a broad estimate. Some people enter remission much earlier, while roughly 20% to 30% of patients experience symptoms that persist beyond 5 years [1][5].

Testing for Remission: Stepping Down Medication

If your hives have been completely controlled for a long time, you and your doctor might wonder if your CSU has entered natural remission. International medical guidelines provide clear instructions on how doctors should increase your medication to get hives under control, but there is no single, universally agreed-upon schedule for how to stop it [6]. Never change your medication dose or schedule without consulting your prescribing clinician.

When deciding to step down treatment, the approach depends heavily on the medication:

  • For Antihistamines: Second-generation antihistamines do not generally cause physical withdrawal, so they don’t strictly require a taper to safely stop. However, as a test to see if your disease is still active, your doctor may instruct you to gradually reduce the dose or take the medication less frequently before stopping entirely [7].
  • For Biologics (like omalizumab): There is no universally validated tapering schedule for omalizumab. Many clinicians prefer to wait until a patient has been completely symptom-free for about 6 months before trying to step down [6]. When they do, some specialists use an individualized strategy—which may be off-label—such as gradually increasing the time between your injections or lowering the dose [8].

The Risk of Symptoms Returning

It is common to experience a recurrence of hives or swelling when you reduce or stop your medication. This does not mean you are going through withdrawal; it simply means the underlying disease is still active and requires ongoing suppression.

When biologic medications like omalizumab are withdrawn, observational studies suggest that symptoms return in roughly 50% of patients, though reported rates vary from about 30% to nearly 67% depending on the specific study and follow-up period [9][10][11]. Symptoms may return within days, weeks, or months after stopping treatment [12][13].

If your hives do return, a relapse does not mean treatment failure. Many patients who experience a recurrence will regain control of their symptoms once they restart their previously effective treatment [14][8]. However, the timing of this response varies. It is vital to have a clear “restart plan” agreed upon with your clinician in advance so you know exactly what to do and when to contact them if symptoms reappear.

Common questions in this guide

Can chronic spontaneous urticaria really go away on its own?
Yes. Many people with CSU eventually enter remission, meaning their hives and swelling stop without medication, but the timing and whether remission lasts vary; some people have symptoms for more than five years.
How can I tell whether I am in remission or just controlled by medicine?
If hives are absent while you take medication, CSU may still be active beneath the treatment. A clinician may consider a carefully planned step-down after sustained symptom control to see whether symptoms return.
Can I stop my antihistamine or omalizumab when my hives are gone?
Do not change or stop either medication without your prescribing clinician’s guidance. Second-generation antihistamines usually do not cause physical withdrawal, while omalizumab has no universally validated tapering schedule, so the plan must be individualized.
How likely are hives to return after stopping omalizumab?
Observational studies suggest that symptoms return in about half of patients after omalizumab is withdrawn, although reported rates vary. Symptoms may return within days, weeks, or months; recurrence reflects active CSU rather than withdrawal and does not necessarily mean treatment failure.
How long should I be symptom-free before trying to stop omalizumab?
There is no universally agreed schedule, but many clinicians wait until a patient has been completely symptom-free for about six months before considering a step-down. The timing and method should be decided individually with the prescribing clinician.
Which CSU symptoms require emergency medical help?
Seek emergency care immediately for swelling of the tongue, lips, or throat; trouble breathing or swallowing; a voice change; or dizziness or fainting. If you have an epinephrine auto-injector, use it according to your emergency plan and seek care rather than waiting for routine medication to work.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What specific criteria (such as being completely hive- and swelling-free for a certain number of months) do you look for before we test if I am in remission?
  2. 2.If we decide to reduce my medication, what exact schedule will we follow, and is this part of a standard protocol or an individualized approach?
  3. 3.If my hives return during or after stopping the medication, what is our exact action plan for restarting treatment?
  4. 4.At what point should I contact your office if my symptoms return, versus waiting for the restarted medication to work?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    The future of targeted therapy in chronic spontaneous urticaria.

    Min TK, Saini SS

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2024; (133(4)):367-373 doi:10.1016/j.anai.2024.05.020.

    PMID: 38885835
  2. 2

    Clinical Course of Chronic Spontaneous Urticaria in the Korean Adult Population.

    Kim YS, Park SH, Han K, et al.

    Allergy, asthma & immunology research 2018; (10(1)):83-87 doi:10.4168/aair.2018.10.1.83.

    PMID: 29178681
  3. 3

    Clinical Remission of Chronic Spontaneous Urticaria (CSU): A Targeted Literature Review.

    Balp MM, Halliday AC, Severin T, et al.

    Dermatology and therapy 2022; (12(1)):15-27 doi:10.1007/s13555-021-00641-6.

    PMID: 34807372
  4. 4

    Prospective analysis of clinical evolution in chronic urticaria: Persistence, remission, recurrence, and pruritus alone.

    Sánchez J, Álvarez L, Cardona R

    The World Allergy Organization journal 2022; (15(10)):100705 doi:10.1016/j.waojou.2022.100705.

    PMID: 36267098
  5. 5

    Chronic Spontaneous Urticaria: The Devil's Itch.

    Saini SS, Kaplan AP

    The journal of allergy and clinical immunology. In practice 2018; (6(4)):1097-1106 doi:10.1016/j.jaip.2018.04.013.

    PMID: 30033911
  6. 6

    A global perspective on stepping down chronic spontaneous urticaria treatment: Results of the Urticaria Centers of Reference and Excellence SDown-CSU study.

    Türk M, Kocatürk E, Ertaş R, et al.

    Clinical and translational allergy 2024; (14(2)):e12343 doi:10.1002/clt2.12343.

    PMID: 38353300
  7. 7

    [Diagnostic and Therapeutic Approach of Chronic Spontaneous Urticaria: Recommendations in Portugal].

    Costa C, Gonçalo M,

    Acta medica portuguesa 2016; (29(11)):763-781 doi:10.20344/amp.8294.

    PMID: 28229846
  8. 8

    Remission of chronic urticaria in patients treated with omalizumab.

    Cvenkel K, Bizjak M, Šelb J, Košnik M

    Acta dermatovenerologica Alpina, Pannonica, et Adriatica 2024; (33(2)):59-61.

    PMID: 38741391
  9. 9

    Predictors of relapse after omalizumab withdrawal in chronic spontaneous urticaria: Role of baseline autoimmunity and hematologic indices: CSU Relapse After Omalizumab Withdrawal.

    Koc Yildirim S, Erbagci E, Demirel Ogut N, et al.

    Allergy and asthma proceedings 2026; (47(1)):32-39 doi:10.2500/aap.2026.47.250089.

    PMID: 41514184
  10. 10

    Experience with Omalizumab for the treatment of chronic spontaneous urticaria in a tertiary center: real life experience.

    Acar A, Gerceker Turk B, Ertam Sagduyu I, et al.

    Cutaneous and ocular toxicology 2020; (39(3)):249-253 doi:10.1080/15569527.2020.1787432.

    PMID: 32597235
  11. 11

    Remission of chronic spontaneous urticaria following omalizumab with gradually extended dosing intervals: Real-life data.

    Salman A, Aktas M, Apti Sengun O

    The Australasian journal of dermatology 2021; (62(3)):398-402 doi:10.1111/ajd.13656.

    PMID: 34156714
  12. 12

    Relapse rates and associated risk factors following omalizumab treatment in adolescents with chronic spontaneous urticaria.

    Caka C, Ocak M, Duran BC, et al.

    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 2025; (36(10)):e70216 doi:10.1111/pai.70216.

    PMID: 41036611
  13. 13

    From regulatory limitations to new opportunities: Real-life experience on the effectiveness of short courses of omalizumab in the treatment of chronic idiopatic urticaria.

    Papaianni V, Guarneri F, Vaccaro M, et al.

    Dermatologic therapy 2020; (33(1)):e13188 doi:10.1111/dth.13188.

    PMID: 31837248
  14. 14

    Omalizumab Re-Treatment and Step-Up in Patients with Chronic Spontaneous Urticaria: OPTIMA Trial.

    Sussman G, Hébert J, Gulliver W, et al.

    The journal of allergy and clinical immunology. In practice 2020; (8(7)):2372-2378.e5 doi:10.1016/j.jaip.2020.03.022.

    PMID: 32272284

This page explains remission and medication step-down for chronic spontaneous urticaria for informational purposes only and does not constitute medical advice. Do not change or stop treatment without your prescribing clinician’s guidance, and seek emergency care for breathing or throat-swelling symptoms.

Get notified when new evidence is published on chronic idiopathic urticaria.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.